ASPEN PHAR.UN.ADR /1 O.N. Cash Flow Quality Index
ASPEN PHAR.UN.ADR /1 O.N. cash flow quality index. ASPEN PHAR.UN.ADR /1 O.N. (LDZU) has a Cash Flow Quality Index of 1.41x as of June 2024. Operating cash flow of €6.22 Billion exceeds net income of €4.40 Billion, indicating high earnings quality where cash backs reported profits. Explore how well can ASPEN PHAR.UN.ADR /1 O.N. service its debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of ASPEN PHAR.UN.ADR /1 O.N. (2022–2024)
Cash flow quality index of ASPEN PHAR.UN.ADR /1 O.N. from 2022 to 2024. Historical Cash Flow Quality Index for ASPEN PHAR.UN.ADR /1 O.N. across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. See net asset quality index of ASPEN PHAR.UN.ADR /1 O.N. to measure how much of total assets are equity-financed.
ASPEN PHAR.UN.ADR /1 O.N. Cash Flow Quality Index by Year (2022–2024)
ASPEN PHAR.UN.ADR /1 O.N. cash flow quality index by year from 2022 to 2024. Year-by-year earnings quality comparison for ASPEN PHAR.UN.ADR /1 O.N.. For the full cash flow conversion analysis, see how efficiently does ASPEN PHAR.UN.ADR /1 O.N. generate cash.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.41x | €6.22 Billion | €4.40 Billion | ▲ +33.9% |
| 2023 | 1.06x | €5.52 Billion | €5.23 Billion | ▲ +27.5% |
| 2022 | 0.83x | €5.37 Billion | €6.49 Billion | — |